CP50: Sumitomo Chemical America Inc.

Company Information

The origins of Sumitomo Chemical can be traced back to 1913 when the company used sulfur dioxide emissions from the Besshi Copper Mine in the Shikoku region of Japan to produce calcium superphosphate fertilizers, thereby reducing pollution from the mine. In addition to helping preserve the environment by preventing the emission of pollutants, the company was thereby also able to contribute toward increasing the harvest of agricultural products. Sumitomo Chemical thus found its start with the solving of environmental problems and the goal of improving living standards. Today, the Sumitomo Chemical Group includes some 100 companies operating around the world in six business sectors: basic chemicals, petrochemicals and plastics, fine chemicals, IT-related chemicals, agricultural chemicals, and pharmaceuticals. Sumitomo Chemical's U.S. headquarters is based in New York. The parent headquarters is located in Tokyo, Japan. The majority of the company's sales is based in the petrochemicals sector, comprising 32% of total company sales.

Company Officers

  • Yoshimasa Takao

    Executive Vice President

    Takao has been serving as executive vice president and representative director in at Sumitomo Chemical since April 1, 2012, according to Reuters news service. He joined the company in April 1973. He previously served as managing executive officer, senior managing executive officer and director of the company's human resources office.

  • Tokura

    Masakazu Tokura

    President and COO

    Tokura has has been serving as president of Sumitomo Chemical since April 1, 2011, according to Reuters news service. He joined the company in April 1974. He previously served as managing executive officer, senior managing executive officer and director of business integration preparation office of the company. He obtained his bachelor's degree in economics from University of Tokyo in March 1974.

  • Osamu Ishitobi

    Chairman, CEO and Representative Director

    Ishitobi was named chairman and CEO of Sumitomo Chemical Company Ltd. effective June 24, 2014. He previously served as vice chairman of the board, executive officer of Sumitomo Chemical, according to Reuters news service. He also has served as representative director since 2012. He joined the company in April 1969. His previous titles include senior managing executive officer, managing director, managing executive officer, executive vice president and director of petrochemical operation office in the company.

Investor Information

For the latest financial reports, visit: http://www.sumitomo-chem.co.jp/english/ir/index.html

Contact Information

  • Sumitomo Chemical America Inc.
  • 335 Madison Ave Rm 830
  • New York, N.Y. 10017-4621
Back to the CP50 List
Featured content related to Sumitomo Chemical America Inc.


Sumitomo Chemical supplies basic materials to various industries ranging from consumer-goods to high-tech. Its product line includes inorganic and organic industrial chemicals, composite materials, polymethyl methacrylate resin and sheets, and aluminum. The company supplies many kinds of petrochemical products including organic chemicals, plastics such as low-density polyethylene and polypropylene, and synthetic rubber.. The company offers a wide array of specialty products, including organic intermediates and additives, dyestuffs, and functional materials. The IT-related chemicals sector comprises the Optical Materials division,, the Semiconductor Process Materials division and the Electronic Materials division. Sumitomo Chemical has developed a number of plant protection chemicals, ranging from conventional insecticides, fungicides and herbicides to new types of products, including plant growth regulators. These products are marketed in more than 110 countries around the world. Sumitomo Chemical's pharmaceutical business originated from organic synthesis, a technology that was mainly used for dyestuffs until Sumitomo used the technology to make Japan's first synthetic medicines. Sumitomo Chemical's pharmaceutical business is operated by Sumitomo Pharmaceuticals Co., which mainly manufactures and sells prescription drugs, and Nihon Medi-physics Co. Ltd., which manufactures and sells diagnostics.